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Na+ homeostasis is a key regulator of cardiac excitation and contraction. The cardiac
voltage-gated Na+ channel, NaV1.5, critically controls cell excitability, and altered channel
gating has been implicated in both inherited and acquired arrhythmias. Ca2+/calmodulin-
dependent protein kinase II (CaMKII), a serine/threonine kinase important in cardiac
physiology and disease, phosphorylates NaV1.5 at multiple sites within the ﬁrst intracellular
linker loop to regulate channel gating. Although CaMKII sites on the channel have been
identiﬁed (S516, T594, S571), the relative role of each of these phospho-sites in channel
gating properties remains unclear, whereby both loss-of-function (reduced availability)
and gain-of-function (late Na+ current, INaL) effects have been reported. Our review
highlights investigating the complex multi-site phospho-regulation of NaV1.5 gating is
crucial to understanding the genesis of acquired arrhythmias in heart failure (HF) and
CaMKII activated conditions. In addition, the increased Na+ inﬂux accompanying INaL may
also indirectly contribute to arrhythmia by promoting Ca2+ overload. While the precise
mechanisms of Na+ loading during HF remain unclear, and quantitative analyses of the
contribution of INaL are lacking, disrupted Na+ homeostasis is a consistent feature of
HF. Computational and experimental observations suggest that both increased diastolic
Na+ inﬂux and action potential prolongation due to systolic INaL contribute to disruption
of Ca2+ handling in failing hearts. Furthermore, simulations reveal a synergistic interaction
between perturbed Na+ ﬂuxes and CaMKII, and conﬁrm recent experimental ﬁndings of
an arrhythmogenic feedback loop, whereby CaMKII activation is at once a cause and a
consequence of Na+ loading.
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CARDIAC Na+ HANDLING
In cardiac myocytes, intracellular Na+ concentration ([Na+]i) is
a key modulator of Ca2+ cycling, contractility and metabolism,
and is controlled by the balance between Na+ inﬂux and extru-
sion (Figure 1). The major contributors to Na+ entry during the
cardiac cycle are the Na+/Ca2+ exchanger (NCX), the voltage-
dependent Na+ channel (NaV), and the Na+/H+ exchanger
(NHE) with relative contributions of NCX > NaV > NHE
(see Figure 1). Smaller amounts of Na+ also enter the cell
via the Na+/HCO3− and the Na+/K+/2Cl− cotransporters, and
the Na+/Mg2+ exchanger. Na+ efﬂux is controlled primarily
through the Na+/K+ ATPase (NKA) that keeps [Na+]i constant at
steady-state [reviewed in (Despa and Bers, 2013)].
An integrative approach to cellular Na+ handling is critical to
understand how these pathways interact spatially and temporally
to affect cardiac cell function. Indeed, compelling evidence has
accumulated that local [Ca2+]i and [Na+]i gradients exist close to
the cell membrane (Carmeliet, 1992) that depend on the spatial
localization of speciﬁc Na+ and Ca2+ handling proteins and their
isoforms (Figure 1). For example,NKA-α2 ismore concentrated at
the t-tubules (whereasNKA-α1 is homogenously distributed), and
this couldbe important in regulating local cleft [Na+]i and [Ca2+]i
(Berry et al., 2007; Despa and Bers, 2007). NCX is concentrated
at the t-tubules, but only a small NCX fraction colocalizes with
proteins speciﬁc to the dyadic cleft [i.e., L-type Ca2+ channels
(LTCCs) and ryanodine receptors (RyRs; Jayasinghe et al., 2009)].
Nevertheless, functional data indicate that NCX senses an early
and high rise in local vs. bulk [Ca2+]i (Weber et al., 2003a) and
Ca2+ entry via reverse mode NCX can even trigger sarcoplasmic
reticulum (SR) Ca2+ release (Litwin et al., 1998). Moreover, a loss-
of-function mutation in ankyrin-B results in reduced NKA and
NCX protein levels and impaired targeting to the t-tubules, which
causes altered Ca2+ signaling and after contractions (Mohler et al.,
2003) and can affect local [Na+], cellular and SR Ca2+ cycling
(Camors et al., 2012), and kinase/phosphatase balance (DeGrande
et al., 2012).
Cardiac Na+ channel (NaV1.5) activity also requires proper
sarcolemmal localization. For example, defective membrane tar-
geting by impaired interaction of NaV1.5 and ankyrin-G causes
Brugada syndrome (BrS; Mohler et al., 2004). NaV1.5 are found
roughly homogenously distributed in the t-tubules and exter-
nal sarcolemma, whereas non-cardiac NaV isoforms (whose
role is still poorly understood) are more concentrated at the
t-tubules (Brette and Orchard, 2006). However, immunoﬂuo-
rescence studies show NaV1.5 mostly at the intercalated disks,
and it has been proposed that different pools of Na+ channels
are located in the external sarcolemma vs. intercalated disks,
where they interact within different macromolecular complexes
and are regulated differently (Lin et al., 2011; Petitprez et al., 2011;
Sato et al., 2011).
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FIGURE 1 | Schematic showing themainprocesses regulating [Na+]i
and [Ca2+]i homeostasis in cardiacmyocytes and themechanismsby
which an increase in [Na+]i affects [Ca2+]i, contractility, andmetabolism.
Upon cardiacmyocyte electrical excitation, NaV opening initiates theAP
upstroke and allowsNa+ entry (limited to 6–15μmol/L by rapid inactivation). Em
depolarization causes LTCCopenings and consequent Ca2+-inducedSRCa2+
release,which triggers contraction. During relaxation, Ca2+ is reuptaken into
the SRbySERCA, and extruded out of the cytosol throughNCX,which extrudes
the∼10μmol/L Ca2+ that enters via LTCCs and leads to an increase in [Na+]i by
∼32μmol/L during eachAP.NHEbrings in∼2μmol/LNa+ at physiological
intracellular pH (∼16μmol/L during intracellular acidosis).TheNa+/HCO3− and
theNa+/K+/2Cl− cotransporters, and theNa+/Mg2+ exchanger contribute
minimally to the total Na+ entry (∼40–45μmol/L),which is then extruded by
NKA [reviewed in (Despa andBers, 2013)].
Altered Na+ homeostasis through the mechanisms described
above (and in Figure 1) contributes to action potential (AP) and
[Ca2+] cycling dysregulation, leading to arrhythmia, metabolic
imbalance, remodeling and cell death, and is a hallmark of var-
ious cardiac diseases. The search for a common denominator
has pointed to the Ca2+/calmodulin-dependent protein kinase
II (CaMKII). CaMKII is a basophilic serine/threonine kinase
that plays critical roles in cardiac physiology and disease (where
it is often found hyperactive) through phosphorylation of sev-
eral Ca2+ handling proteins and ion channels (Figure 1; Bers
and Grandi, 2009; Anderson et al., 2011). NaV1.5, in partic-
ular, has emerged as a principle CaMKII target. Herein, we
summarize growing evidence indicating an important role for
CaMKII in regulating NaV1.5 gating and cardiomyocyte Na+
homeostasis, with an emphasis on the important interconnec-
tion between Na+ and Ca2+ handling, and consequences for
arrhythmia.
CARDIAC Na+ CHANNEL STRUCTURE AND FUNCTION
The cardiac Na+ channel is responsible for the upstroke of the
cardiac AP and is a critical determinant of cardiac electrical
excitability. The pore forming α-subunit, NaV1.5, is composed of
four core domains (DI–DIV), each containing six transmembrane
segments (S1–S6; ∼230 kD; Figure 2). The positively charged
S4 segments serve as the channel voltage sensors and the S5–S6
segments comprise the ion-conducting pore. Upon depolariza-
tion, the channel rapidly activates (<1ms) producing a large (tens
of nA), transient inward Na+-current, INa, and then undergoes
fast inactivation (within a few ms) through interactions of the
well-described DIII–IV linker IFM motif with the pore (simi-
lar to N-type inactivation in K+ channels). This is followed by
poorly understood slower modes of inactivation (hundreds of ms
to a few s) that likely involve rearrangements of the pore struc-
ture (similar to C-type inactivation in K+ channels). Channels
that fail to completely inactivate, or close and then reopen, give
rise to a persistent, or late Na+ current (INaL). NaV1.5α forms
macromolecular complexes with β-subunits (β1 to β4) and many
other accessory and regulatory proteins that modify channel gat-
ing [extensively reviewed by Abriel (2010); Wilde and Brugada
(2011)]. The intracellular N- and C-termini and linker loops con-
nectingDI–IV are also all involved in channel gating. In particular,
the NaV1.5 I–II cytoplasmic linker loop is the subject of extensive
post-translational regulation, and this region has received much
attention as a hot spot for phosphorylation by CaMKII [reviewed
in (Herren et al., 2013)].
PHOSPHORYLATION OF NaV1.5 by CaMKII
CaMKII activation has been shown to alter the gating proper-
ties of the Na+ channel, as summarized in Table 1. Specif-
ically, CaMKII phosphorylation of NaV1.5 shifts the voltage
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FIGURE 2 | Clustal sequence alignment of NaV1.5 I–II loop across indicated species. Sites are color coded as follows: red font = phosphorylation; green
font = methylation; yellow block = basophilic kinase consensus region; green bounding box = missense BrS mutation; blue block = LQTS mutation.
dependence of inactivation to negative potentials without affect-
ing channel activation, slows recovery from and enhances
entry into slower forms of inactivation, and increases INaL
(Wagner et al., 2006).
The NaV1.5 I–II linker loop interacts with CaMKII
(Ashpole et al., 2012) and contains multiple basophilic kinase
consensus sequences. Mass spectrometry analysis of wild type
NaV1.5 (puriﬁed from mouse heart lysates) revealed sev-
eral sites within this loop that are basally phosphorylated
(Marionneau et al., 2012; Figure 2, red color, and Table 1). Hund
et al. (2010) mutated putative CaMKII consensus sites to non-
phosphorylatable alanine residues and determined that CaMKII
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speciﬁcally phosphorylates S571. When expressed in a heterolo-
gous expression system, the S571A non-phosphorylatable mutant
abolished constitutively active co-expressed CaMKII enhance-
ment of channel inactivation and INaL. On the other hand,
phosphomimetic S571E recapitulated CaMKII effects (but still
in the presence of constitutively active CaMKII). S571 phos-
phorylation was increased in murine (Toischer et al., 2013) and
human heart failure (HF) and canine ischemic cardiomyopathy
(Koval et al., 2012).
Because CaMKII (and other kinases) can phosphorylate non-
canonical sequences, we screened the entire NaV1.5 I–II loop for
CaMKII phosphorylation with an in vitro kinase assay system
(Ashpole et al., 2012). This assay consisted of a tiled peptide array
spanning the entire loop region followed by in vitro phosphory-
lation with recombinant CaMKII and revealed that site S516 was
phosphorylated most efﬁciently by CaMKII (Ashpole et al., 2012).
Immobilized peptides containing S483/S484 and S593/T594 were
also phosphorylated in this assay at much lower efﬁciency. It is
important to consider peptide conformation may change when a
peptide is immobilized or soluble, which can affect kinase access
to phospho-acceptor sites (Bayer et al., 2006). In fact, subse-
quent studies using soluble peptides showed that T594 but not
S483/4 could be phosphorylated, although only at low efﬁcien-
cies. Furthermore, peptide conformation and kinase binding may
be different for the full-length channel, thus affecting its ability to
be phosphorylated. Therefore, additional phosphorylation studies
using full-length NaV1.5 are needed.
Wild type or non-phosphorylatable mutant channels (S516A,
T594A, S571A) were coexpressed with CaMKIIδC in HEK293
cells and voltage-clamped under pipette conditions to acutely
activate CaMKII (with Ca2+ and calmodulin), with or without
CaMKII inhibition [by autocamtide-2 inhibitory peptide (AIP);
Ashpole et al., 2012]. CaMKII shifted steady-state inactivation
(SSI) to hyperpolarizing potentials and increased entry into inac-
tivation, and this was blocked with AIP or by mutating these
sites to non-phosphorylatable alanine. Phosphomimetic S516E
and T594E mutants recapitulated the hyperpolarizing shift in
SSI even in the absence of CaMKII and presence of AIP. In
our hands, however, S571E phosphomimetic mutants showed no
statistically signiﬁcant negative shift in SSI.Moreover, we observed
no enhancement of late INaL in any of the mutants tested, but
we did not coexpress β-subunits, which some have indicated to
be important for INaL (Maltsev et al., 2009). Importantly, the
phosphorylation status of S516 and T594 in native myocytes is
yet to be determined, and more studies are needed to determine
the relative contribution of these sites to speciﬁc channel gating
properties.
FUNCTIONAL CONSEQUENCES OF I–II LOOP
PHOSPHORYLATION: INSIGHT FROM INHERITED MUTATIONS
Structure-function studies of SCN5A channelopathies/inherited
mutations may further an understanding of the functional con-
sequences of NaV1.5 phosphorylation. CaMKII-dependent alter-
ations of NaV1.5 gating are remarkably similar to those caused
by the NaV1.5 mutation 1795insD (Bezzina et al., 1999), which is
associated to patients with mixed long QT syndrome (LQTS) and
BrS phenotypes. DelK1500 is another overlapmutation that causes
both loss and gain of function channel effects and is function-
ally similar to the effects of CaMKII phosphorylation on NaV1.5
(Grant et al., 2002). Experiments and simulations have shown how
the heart rate acts as a switch imparting LQTS or BrS phenotypes
to the same genotype (Veldkamp et al., 2000; Clancy and Rudy,
2002), and we have hypothesized a similar scenario for CaMKII
effects (Grandi et al., 2007). However, 1795insD and delK1500 are
present on the NaV1.5 C-terminus and III–IV loop respectively,
making structural correlation with CaMKII phosphorylation on
the I–II loop difﬁcult. To date, no overlap mutations have been
identiﬁed anywhere within the I–II loop (Remme et al., 2008).
While no overlap mutations are present, several mutations
or polymorphisms have been identiﬁed within the I–II loop
phosphorylation hot spot through studies of LQTS and BrS
patient cohorts. Examination of these mutations may be useful
in dissecting out the structure-function relationship of kinase
phosphorylation within this region. More than 30 putative BrS
mutations have been identiﬁed in the I–II loop from residues
416–711 (Kapplinger et al., 2010; Figure 2). Unfortunately, not
all of these have been followed up with functional studies. One
mutation, L567Q, was identiﬁed in a family exhibiting BrS
and sudden infant death syndrome (Priori et al., 2000). When
expressed heterologously, the mutant NaV1.5 channel displayed
a negative shift in inactivation and enhanced entry into inac-
tivation that was not dependent on coexpression of β-subunits
Table 1 | NaV1.5 phosphorylation sites, their associated kinases, and biophysical effects.
Residue Kinase SSI INaL Comments Reference
S516 CaMKII ← ↔ Ashpole et al. (2012)
T594 CaMKII ← ↔ Ashpole et al. (2012)
S571 CaMKII ← ↑ Basally phosphorylated by MS Hund et al. (2010), Koval et al. (2012),
Marionneau et al. (2012)
S525 PKA ← ND EP effects are indirect; mutant EP studies ND Zhou et al. (2000)
S528 PKA ← ND EP effects are indirect; mutant EP studies ND Zhou et al. (2000)
S457, S460, S483/4, S497,
S510, S524/5, S664, S667
ND ND ND MS identiﬁcation; basal phosphorylation in untreated
mouse heart lysates; responsible kinases ND
Marionneau et al. (2012)
EP = electrophysiological; ND = not determined; MS = mass spectrometry.
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(Wan et al., 2001). Another mutation, T512I, was identiﬁed in
a patient exhibiting cardiac conduction disease, and resulted in
hyperpolarizing shifts in SSI and activation and enhanced slow
inactivation (Viswanathan et al., 2003). Not only is this mutation
juxtaposed to one of the known CaMKII phosphorylation con-
sensus regions identiﬁed at R513 and phosphorylated at S516 [see
Figure 2 and (Ashpole et al., 2012)], it also functionally mirrors
the enhanced inactivation conferred by CaMKII phosphoryla-
tion at S516. Furthermore, PKA phosphorylation of nearby S525
and S528 (Murphy et al., 1996) has been previously described to
similarly shift the voltage dependence of inactivation to negative
potentials (Zhou et al., 2000). Thus, phosphorylation by either
PKA (S525, S528) or CaMKII (S516) within a short ∼10 amino
acid stretch results in similar channel biophysics compared with
the loss of function BrS mutation identiﬁed at T512. Moreover,
a recent proteomics study demonstrated that residues R513 and
R526within this same region can bemethylated, but the functional
effect of this post-translationalmodiﬁcation is unknown (Beltran-
Alvarez et al., 2011). Another mutation, G514C, was identiﬁed in
a family with cardiac conduction disease. Under voltage clamp,
this mutation displayed a mixed biophysical phenotype of desta-
bilized inactivation and decreased activation (Tan et al., 2001).
These observations cement the importance of this short region in
voltage-dependent inactivation of the channel.
CaMKII-dependent phosphorylation at S571 has been shown
to result in both loss and gain of channel function (Hund et al.,
2010). The functional effects of a negative charge at this site
from CaMKII phosphorylation were suggested to phenocopy the
adjacent inherited LQTS charge mutations at A572D and Q573E
(Koval et al., 2012). Although A572D was initially identiﬁed as
a causative LQTS mutation (Tester et al., 2005), a subsequent
study showed that this mutation is actually a benign variant and
does not cause LQTS in and of itself (Tester et al., 2010). Sim-
ilarly, a mutation identiﬁed in a LQTS patient at 619 was also
attributed to an observed LQTS phenotype in this patient. This
L619F mutation was found to induce INaL when expressed in
a heterologous expression system (Wehrens et al., 2003). How-
ever, a LQTS screening study from the Roden group failed to
detect any late INaL (or gating changes) from L618F mutants
expressed in heterologous cells and concluded this mutation is
also a benign variant (Yang et al., 2002). Indeed, mutations within
the NaV1.5 I–II loop have poor disease predictive value stemming
from the high incidence of benign variants within this region
(Kapa et al., 2009).
Thus, a clear and consistent role for the NaV1.5 I–II loop in
loss of function inactivation gating emerges from studies of kinase
phosphorylation (both CaMKII and PKA) and inherited muta-
tions within this hotspot. There is less evidence for this loop
region mediating INaL effects, with different groups providing
contradictory results. It remains to be determined whether other
unidentiﬁed CaMKII phospho-sites exist on other intracellular
loops of NaV1.5 that maymediate (contribute to) enhancement of
INaL (e.g., the C-terminus (Coyan et al., 2014) or III–IV loopwhere
overlap mutations have been identiﬁed). It is also conceivable that
INaL enhancement in pathological conditions could be due to an
increase in neuronal Na+ channel isoforms with higher fractional
INaL (Xi et al., 2009; Biet et al., 2012; Yang et al., 2012; Toischer
et al., 2013). Alternatively, the effect of CaMKII to augment INaL
may require accessory proteins not present in heterologous cell
systems [such as regulatory β subunits (Maltsev et al., 2009)].
Indeed, this emphasizes the need for studies of these phospho-
rylation sites in native adult cardiomyocytes. Human induced
pluripotent stem cells may also be used as suitable models, as
has been done for some inherited mutations, such as 1795insD
(Davis et al., 2012).
Enhanced inactivation and consequent reduction in channel
availability due to CaMKII phosphorylation is expected to con-
tribute to re-entrant arrhythmias from slowed conduction and
enhanced dispersion of repolarization [as we have extensively
reviewed previously (Herren et al., 2013)]. On the other hand,
CaMKII enhancement of INaL, while not as well understoodmech-
anistically, can also lead to arrhythmias arising from prolonged
AP duration (APD) that makes the cell more vulnerable to trig-
gered activity [via early after-depolarizations (EADs)]. EADs are
favored by conditions leading to prolongation of the AP plateau
within a voltage range permitting recovery from inactivation and
reactivation of LTCC, or can be the consequence of SR Ca2+
release and consequent augmentation of NCX current. A novel
and unique mechanism underlying phase 3 EADs in ventricular
myocytes from CaMKIIδC overexpressing mice has been recently
described (Edwards et al., 2012), which involves isoproterenol-
induced exaggerated Ca2+ release, increased inward NCX current,
and non-equilibrium reactivation of fast INa.
INaL AND CELLULAR Na+ LOADING IN HF
In addition to directly affectingmyocytes electrical stability, INa is a
major pathwayof Na+ inﬂux into cardiacmyocytes, althoughNCX
plays the most dominant role both at rest and in contracting cells
[see Figure 1 and (Despa and Bers, 2013)]. In normal myocytes
INaL contribution to Na+ entry is limited, but when INaL is
enhanced in diseased conditions (such as cardiac hypertrophy and
HF) it carries as much Na+ as the fast INa transient, thus increas-
ing total cellular Na+ inﬂux during a cardiac cycle and potentially
contributing to Na+ overload (Makielski and Farley, 2006; Despa
and Bers, 2013). Indeed, intracellular Na+ concentration ([Na+]i)
is increased in myocytes from failing hearts compared to non-
failing myocytes by 2–6 mM (Pogwizd et al., 2003; Shryock et al.,
2013), but the precise mechanism(s) remains unclear (Figure 3).
It has been suggested that CaMKII and enhanced INaL contribute
to [Na+]i elevation in HF, as CaMKIIδC overexpressing mice with
HF exhibit prominent INaL and have increased [Na+]i (Wagner
et al., 2006).
While the increase in INaL may play a role in the observed
[Na+]i loading in these transgenic mice (Wagner et al., 2006),
we demonstrated that CaMKII-dependent enhancement of INaL
is not quantitatively sufﬁcient to account for the [Na+]i elevation
observed in HF (Grandi et al., 2007; Wagner et al., 2011; Moreno
et al., 2013; Morotti et al., 2014). Additionally, in a rabbit model
of pressure- and volume-overload-inducedHF,Despa et al. (2002)
reported an increased Na+ inﬂux resulting primarily from a TTX-
sensitive pathway,which accounted for a gain in [Na+]i of∼3mM,
and was present both in resting and electrically stimulated cells.
This supports the existence of a diastolic Na+ inﬂux in failing
myocytes responsible for [Na+]i elevation, although it is currently
www.frontiersin.org March 2014 | Volume 5 | Article 41 | 5
Grandi and Herren CaMKII-dependent regulation of cardiac Na+ homeostasis
FIGURE 3 | CaMKII activation and Na+ homeostasis are intimately
related in the regulation of cellular Ca2+, contractility and electrical
stability.With CaMKII hyperactivity, increase in late INa favors AP
prolongation and EADs. Cellular Na+ loading increases Ca2+, via outward
shift in NCX, which further activates CaMKII, fueling a vicious cycle that
favors spontaneous SR Ca2+ release and predisposes to Ca2+-related
arrhythmia. Elevated [Na+]i can also inﬂuence ROS production by affecting
mitochondrial [Ca2+]i. A less appreciated observation is that high [Na+]i by
causing outward shifts in both NCX and NKA will tend to shorten the AP, as
predicted by computational AP models (Grandi et al., 2010, 2011). We
speculate that the increased [Na+]i in HF may limit AP prolongation caused
by reduced K+ channel conductance and increased INaL.
unclear whether this diastolic inﬂux is carried by NaVs [whether
they be of cardiac, neuronal, or skeletalmuscle isoforms (Biet et al.,
2012; Yang et al., 2012)] or by which gating mechanism. Increases
of Na+ window and/or background current can potentially con-
tribute to increased Na+ inﬂux in failing vs. normal myocytes
[and could be modiﬁed by drugs affecting the voltage dependence
of Na+ channel gating (Shryock et al., 2013)]. We showed that
simulation of an increased sarcolemmal Na+ leak current allows
recapitulating the [Na+]i gain seen in HF (Wagner et al., 2011;
Moreno et al., 2013; Morotti et al., 2014). Baartscheer et al. (2003)
using the same pressure- and volume-overload rabbit HF model
in Despa et al. (2002) found that increased Na+ inﬂux via NHE
was the largest contributor to the elevated Na+ inﬂux rate and
[Na+]i in paced myocytes. Interestingly, CaMKII activates NHE
(Vila-Petroff et al., 2010). Reduced Na+ extrusion could also con-
tribute to the observed intracellular Na+ gain during HF. Despite
reduced expression, NKA function is unchanged in HF (Despa
et al., 2002; Baartscheer et al., 2003), which is possibly due to
higher NKA function secondary to reduced relative expression
and elevated phosphorylation of phosholemman (Bossuyt et al.,
2005).
CONSEQUENCES OF Na+ LOADING ON
EXCITATION-CONTRACTION COUPLING
[Na+]i elevation in HF is expected to limit Ca2+ extrusion via
forward mode NCX, and could even favor Ca2+ entry via reverse
mode NCX (Weber et al., 2003b; Figures 1 and 3). Slowing Ca2+
extrusion via NCX will tend to elevate diastolic [Ca2+]i, thereby
contributing to diastolic dysfunction. The slowed [Ca2+]i decline
and elevated diastolic [Ca2+]i will also tend to increase SR Ca2+
content, thus exerting a positive inotropic effect and enhancing
contractility. This explains the efﬁcacy of cardiac glycosides in the
treatment of congestive HF. These compounds promote inotropy
by selectively inhibiting NKA and thereby impairing Na+ extru-
sion and weakening the NCX Ca2+ extrusion gradient. However,
they are well known for having undesired arrhythmic conse-
quences (Altamirano et al., 2006) by increasing the propensity for
spontaneous SR Ca2+ release and delayed after-depolarizations
(DADs). DADs arise from a transient inward current Iti through
forward mode NCX, which is evoked by the sudden increase in
[Ca2+]i. It has been recently proposed that CaMKII is mechanisti-
cally involved in glycoside-induced arrhythmogenesis, as ouabain
increased CaMKII activity, and CaMKII inhibition signiﬁcantly
reduced ouabain-induced spontaneous contractile activity and
Ca2+ waves (Gonano et al., 2011). CaMKII overexpression exacer-
bated ouabain-induced spontaneous contractile activity (Gonano
et al., 2011), possibly by favoring spontaneous SRCa2+ release and
DADs, as demonstrated in a recent computational mouse model
(Morotti et al., 2014). Ouabain-induced [Na+]i loading has also
been shown to result in apoptosis (Sapia et al., 2010), mediated
by reverse mode NCX-dependent activation of CaMKII. Thus,
CaMKII inhibition may have potential therapeutic beneﬁt during
glycoside treatment to prevent arrhythmia and cell death while
minimally impacting the positive inotropic effect. Analogously,
the Na+ channel opener ATX-II induces spontaneous diastolic
Ca2+ release from the SR and DADs in myocytes (Song et al.,
2008) and arrhythmia in Langendorff perfused hearts (Yao et al.,
2011), which is attenuated with CaMKII or INaL inhibition.
Our recent model of the failing human ventricular myocyte
conﬁrmed that a 20% increase in [Na+]i in HF compared to
control conditions slows forward mode inward NCX (Ca2+
extrusion) and enhances reverse mode NCX (Ca2+ entry, at
the beginning of the AP; Moreno et al., 2013). This, cou-
pled with AP prolongation due to extensive ionic remodeling
in HF (including enhanced INaL), increased diastolic [Ca2+]i
while maintaining adequate SR Ca2+ load and Ca2+ transient
despite reduced SR Ca2+-ATPase (SERCA) function. However,
[Na+]i-induced Ca2+ enhancement, in combination with hyper-
phosphorylated RyRs, causes diastolic SR Ca2+ release, Iti, and
triggered APs [Figure 3, also favored by a more depolarized
resting membrane potential (Em) in HF, due to decreased IK1
and increased background Na+ current]. Simulations showed
that by targeting pathological late Na+ current and diastolic
Na+ inﬂux, ranolazine (1) limits [Na+]i thus restoring normal
NCX forward mode that speeds up Ca2+ extrusion, (2) shortens
APD, thus further limiting Ca2+ entry, and (3) hyperpolarizes
the Em, which elevates the threshold of triggered APs. These
simulation results are consistent with recent experimental data
in human failing myocytes from hypertrophic cardiomyopathy
samples (Coppini et al., 2013). Similarly, CaMKII-dependent
[Na+]i elevation (normalized by ranolazine) has been associ-
ated with diastolic dysfunction and arrhythmias in CaMKIIδC
overexpressingmicewithHF (Sossalla et al., 2011). Taken together,
these observations suggest that limiting [Na+]i overload may
be an appropriate antiarrhythmic therapeutic for the prevention
of diastolic tension and arrhythmia triggers driven by [Ca2+]i
loading.
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ARRHYTHMOGENIC CaMKII–Na+–Ca2+–CaMKII FEEDBACK
It has been proposed that [Ca2+]i loading caused by elevated
[Na+]i in HF may positively feed back to further activate CaMKII
(and enhance target phosphorylation) thus creating an arrhyth-
mogenic vicious circle. This positive feedback from Na+ to Ca2+
to CaMKII to Na+ has been qualitatively described for Na+
loading induced by ATX-II or accompanying a LQT3 mutation
associated with increased INaL (Yao et al., 2011). Both of these con-
ditions increased [Ca2+]i, induced CaMKII activation, increased
CaMKII-dependent phosphorylation of phosholamban and RyRs,
and favored arrhythmias. Although a CaMKII-dependent increase
in NaV phosphorylation was not directly conﬁrmed in that study,
a [Ca2+]i-dependent increase in INaL involving both CaMKII and
PKC has previously been demonstrated (Ma et al., 2012). Accord-
ingly, blockade of INa or INaL with TTX or ranolazine reversed all
these effects, as didCaMKII inhibition viaAIP orKN-93 (Yao et al.,
2011). Our recently developedmousemyocyte model showed that
alterations in Na+ handling accompanying transgenic CaMKII
overexpression (namely, increase in systolic INaL and diastolic Na+
leak) can increase intracellular Na+ gain to initiate Ca2+ overload
and CaMKII activation. Furthermore, this mechanism proved to
be quantitatively sufﬁcient to further disrupt Ca2+ (and Na+)
homeostasis and promote cellular arrhythmias (Morotti et al.,
2014). The simulated effect of Na+ loading to fuel CaMKII-Na+-
Ca2+-CaMKII feedback was even more striking when CaMKII
was further activated by isoproterenol. This is consistent with the
observation that β-adrenergic stimulation of myocytes isolated
from mice overexpressing CaMKII (Sag et al., 2009) or subjected
to TAC-induced HF (Toischer et al., 2013) increased the number
of DADs, which were largely prevented by either ranolazine or AIP
(Toischer et al., 2013).
CONSEQUENCES OF [Na+]i LOADING ON CARDIAC
ENERGETICS
[Na+]i is also important in regulating cardiac myocyte bioener-
getics, by controlling mitochondrial [Ca2+] via the mitochondrial
NCX, and critically regulating the production of mitochondrial
reactive oxygen species (ROS, Figure 1). High [Na+]i in HF may
negatively affect cardiac metabolism during rapid pacing, as ele-
vated [Na+]i has been shown to impair frequency-induced mito-
chondrial [Ca2+] accumulation therebydecreasingNADH/NAD+
redox potential, and increasing H2O2 formation inmyocytes from
failing hearts (Liu and O’Rourke, 2008). Notably, higher oxida-
tive stress may further exacerbate [Na+]i loading by enhancing
INaL through direct effects on NaV1.5 or secondarily by activat-
ing CaMKII (Wagner et al., 2011). This suggests the interesting
notion that ROS, like Na+, is both a cause and consequence of
CaMKII activation. Not only does oxidative stress activate CaMKII
directly (Erickson et al., 2008), but CaMKII-induced [Na+]i load-
ing can induce an increase in ROS (Figures 1 and 3). This parallels
recent evidence indicating that CaMKII regulates ROS production
(Pandey et al., 2011; Sepulveda et al., 2013; Zhu et al., 2014). Li
et al. (2012) put forward an intriguing model-based hypothesis
that Na+ accumulation in the SERCA knock-out mouse, which
occurs secondary to marked NCX upregulation and intracellu-
lar acidosis, might play a role in the development of HF in
these animals. This mechanism acts by initiating a reinforcing
cycle involving a mismatch between ATP supply and demand,
increasingly compromised metabolism, decreased intracellular
pH, and further elevation of [Na+]i due to NHE, which may
shift the time of transition from compensated to decompensated
function.
CONCLUDING REMARKS
CaMKII-dependent loss and gain of function effects on NaV1.5
gating are pro-arrhythmic and functionally phenocopy SCN5A
inherited mutations causing LQTS and BrS. Analogous to BrS
mutations, CaMKII-dependent loss of Na+ channel function and
consequent reduction in Na+ channel availability slows cardiac
conduction and increases the propensity for conduction block
and re-entry. Evidence points to the I–II loop phosphorylation
hot spot as a likely mediator of these loss-of-function effects.
Conversely, CaMKII enhancement of INaL, while not as well
understood, may prolong the APD and predispose to lethal ven-
tricular tachyarrhythmia (as in LQTS). Further study of these
mechanisms may provide important advances for rational design
of novel antiarrhythmic therapeutics. Additionally, experimental
data and quantitative ﬁndings support the intriguing hypothe-
sis that drugs designed to correct aberrant Na+ channel gating
behavior, causing INaL and cellular Na+ loading, may act impor-
tantly by reducing Ca2+ overload. Growing evidence suggests that
prevention of Na+-dependent Ca2+ overload is a key mechanism
of action for these compounds (Sossalla et al., 2011; Yao et al.,
2011). Inhibition of intracellular Na+ loading can contribute to
normalizing Ca2+ and Em homeostasis in HF, but should not be
achieved at the expense of systolic function. Inhibition of CaMKII
or its targets may be an attractive means of facilitating these
outcomes.
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